REG - Impact Healthcare - Notice of Full Year Results

Impact Healthcare REITAnnouncement

11/03/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240311:nRSK2127Ga&default-theme=true

RNS Number : 2127G  Impact Healthcare REIT PLC  11 March 2024

 

11 March 2024

Impact Healthcare REIT plc

("Impact" or the "Company" or, together with its subsidiaries, the "Group")

NOTICE OF ANNUAL RESULTS FOR THE 12 MONTHS ENDED 31 DECEMBER 2023

Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust
which gives investors exposure to a diversified portfolio of UK healthcare
real estate assets, in particular care homes, expects to announce its annual
results for the 12 months ended 31 December 2023 on Monday, 25 March 2024.

 

A Company presentation for analysts and investors will take place on the day
at 8.30am (UK) via an in-person meeting and a live webcast and conference
call.

 

To attend the in-person presentation, please contact:

impacthealth-maitland@h-advisors.global
(mailto:impacthealth-maitland@h-advisors.global)

 

To view the live webcast, please register in advance at:

https://stream.brrmedia.co.uk/broadcast/65e9a4042cbb0478a930d370
(https://stream.brrmedia.co.uk/broadcast/65e9a4042cbb0478a930d370)

 

The conference call dial-in is available using the below details:

 Phone number:              +44 (0) 33 0551 0200
 Participant access quote:  Impact Healthcare - Full Year Results

 

If you would like to ask your questions verbally, please use the dial in
number. Alternatively, you can type questions into the webcast question box.

 

The presentation will also be accessible on demand later in the day on the
Company's website: www.impactreit.uk (http://www.impactreit.uk/)

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 Impact Health Partners LLP                                                             Via H/Advisors Maitland
 Andrew Cowley
 David Yaldron

 Jefferies International Limited                                                        020 7029 8000
 Tom Yeadon                                    tyeadon@jefferies.com
 Neil Winward                                  nwinward@jefferies.com
 Ollie Nott                                    onott@jefferies.com

 Winterflood Securities Limited                                                         020 3100 0000
 Neil Langford                                 neil.langford@winterflood.com
 Joe Winkley                                   joe.winkley@winterflood.com

 H/Advisors Maitland (Communications advisor)  impacthealth-maitland@h-advisors.global
 James Benjamin                                                                         07747 113 930
 Rachel Cohen                                                                           020 7379 5151
 Billy Moran                                                                            020 7379 5151

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

Further information on Impact Healthcare REIT plc is available at
www.impactreit.uk (http://www.impactreit.uk/) .

 

NOTES:

Impact Healthcare REIT plc acquires, renovates, extends and redevelops high
quality healthcare real estate assets in the UK and lets these assets on
long-term full repairing and insuring leases to high-quality established
healthcare operators which offer good quality care, under leases which provide
the Company with attractive levels of rent cover.

 

The Company aims to provide shareholders with an attractive sustainable
return, principally in the form of quarterly income distributions and with the
potential for capital and income growth, through exposure to a diversified and
resilient portfolio of UK healthcare real estate assets, in particular care
homes for the elderly.

 

The Company's dividend policy is to maintain a progressive dividend that is
covered by adjusted earnings.

 

On this basis, the target total dividend for the year ending 31 December 2024
is 6.95 pence per share(*), a 0.18 pence increase over the 6.77 pence in
dividends paid or declared per ordinary share for the year ended 31 December
2023.

 

The Group's Ordinary Shares trade on the main market of the London Stock
Exchange, premium segment. The Company is a constituent of the FTSE
EPRA/NAREIT index.

*     This is a target only and not a profit forecast. There can be no
assurance that the target will be met and it should not be taken as an
indicator of the Company's expected or actual results.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORFLFLRVTITIIS